During my first year in practice, I met Eileen, a delightful woman who wanted children but sacrificed her fertility by having a radical hysterectomy to cure her cervical cancer. Sometimes I wonder where she is, whether she ever married, if she has adopted children. I hope so, because she would be a wonderful mother. Had she been diagnosed today, she might be a candidate for a fertility-sparing radical trachelectomy, like my current patient, Crystal. Her 5-year-old son was the first child conceived at Duke after fertility-sparing surgery for stage IB cervical cancer.
And I will never forget Sandra, who presented in labor with a 7-cm-dilated cervix that contained a large cancer. A cesarean-radical hysterectomy yielded a healthy baby boy, but the pathology report showed that the cancer had spread to her lymph nodes. Even with chemoradiation, her prognosis was uncertain, and the follow-up visits were agonizing as we held our breath desperately hoping that Sandra was cured. She beat the odds and her son is now in elementary school.
I remember, too, the patients with recurrent cervical cancer who have undergone pelvic exenteration as a last act of desperation and been willing to live with a colostomy and urinary conduit. There was the young African-American woman who developed an incurable recurrence after exenteration. On Vivian's last hospital admission, I was called to discharge her urgently because the bus that provides transportation for patients lacking other means was about to leave. That day was the first anniversary of 9/11. The outpouring of sympathy for those lost in the terrorist attacks was understandably great, but in stark contrast to the barely noticed death of my indigent young patient in rural North Carolina several days later.
In the future, perhaps, women won't have to suffer as did the patients I've described. Not only is the incidence of cervical cancer continuing to fall with advances in screening, but there is a new vaccine against HPV 16 and 18 that has the potential to prevent most cases. I hope it will be widely adopted and prove as effective as predicted, but it will be many years before we can judge the success of this approach. Let's hope, too, that women who are vaccinated will not neglect cervical screening out of a false sense of security. There are other potential pitfalls along the way. It is possible that prevention of HPV 16 and 18 may allow other subtypes to emerge as a major cause of cervical cancer. And will the vaccine's efficacy be compromised if only women are vaccinated?
I say bring on the cervical cancer vaccine in the hope that cervical cancer can become a rare medical curiosity, like polio, smallpox, and other formerly devastating viral infectious diseases!
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More